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Highlights of the HMA Scientific Session
Elizabeth M. Adams MD
Myron Shirasu and his committee again produced an excellent
program. This year there were concurrent sessions on Friday and
Saturday mornings, making it impossible for one person to attend
them all. Where I was not present at a talk I have relied on the
speaker’s handouts and the comments of those who did attend in
preparing this summary.
On Friday, October 31, Dr Laurie K.S. Tom’s topic was the
treatment of type 2 diabetes. Close control of glycemia reduces
complications. When diet, exercise and weight reduction do not
adequately control glucose levels other measures are necessary. The
options are oral agents, insulin, or a combination of the two. Dr Tom
then discussed the use ofthree relatively new oral agents: biguanides,
alpha glucosidase inhibitors and thiazolidinediones.
Dr Michael Kusaka’ s topic was travel medicine. He discussed the
treatment of traveler’s diarrhea; malaria prophylaxis; routine immu
nizations for measles, mumps and rubella, polio, influenza, pneu
mococcal infections, and tetanus and diphtheria; and immunization
for yellow fever, hepatitis A and B, Japanese encephalitis, rabies,
typhoid, meningococcal infections, and when and where these are
recommended.
Dr Michael Moore (Bowman Gray School of Medicine) gave two
presentations. In the first, “Strategies to Improve Cardiovascular
Health in Hawaii”, he discussed the need to treat hypertension
aggressively, to reduce obesity, chronic alcohol use, and fat and
sodium intake.
In his second talk Dr Moore discussed the evaluation and treat
ment of hematuria and albminuria in children. One should be
concerned if there are more than 3 rbclhpf. Management will vary
with the cause, which will vary with the age of the child. Persistent
proteinuria, in the absence of infection, indicates glomerulara dis
ease. Nephrotic proteinuria, is treated with prednisone.
Dr Carla Nip-Sakamoto discussed common dermatologic prob
lems in children. The risk of melanoma developing in a small or
intermediate (<20 cm.) congenital melanocytic nevus is 1-5%.
However with a giant congenital nevus the risk is 5-12%, with 60%
of the melanomas occurring in the first ten years of life. The smaller
nevi should be removed before puberty, but the larger ones at 3-6
months of age. 2% of malignant melanomas occur before age 20, 30
% of these arising in giant melanocytic nevi. Dr Nip-Sakamoto then
described various types of atopic dermatitis and their treatment, and
classification and treatment of acne vulgaris, types of alopecia, and
new therapeutic agents.
Dr Gregory Chow discussed childhood and adolescent orthopedic
problems.
Dr John McDonnell’s topic was adolescent smoking, which is
increasing after declining for several years. He described the ploys
which tobacco companies use to lure children and teens to smoke,
the adverse effects of smoking (pulmonary and cardiovascular
disease, increased risk of lung, laryngeal, oral and other cancers, and
other conditions). Addiction to nicotine occurs early and it is then
very difficult to quit. Smoking kills more people every year than
alcohol and other drugs, car accidents, suicides, AIDS, homicides
and fires combined. Exposure to environmental tobacco smoke
carries risks similar to those of active smoking. Smoking during
pregnancy increases the risk of miscarriage, fetal death, and low
birth weight infants. Although the risks of smoking are well known,
many physicians do not advise their patients to stop nor offer
assistance with quitting. Since most smokers begin the habit in
childhood and adolescence increased efforts to curtail juvenile
smoking are urgently needed.
Saturday morning’s program began with Dr Naoki C.S. Tsai
discussing “The ABC’s of Hepatitis”.
Hepatitis A accounts for 45% of acute viral hepatitis in the US,
hepatitis B for 35% of acute viral hepatitis and 25% of chronic, and
hepatitis C for 17% of acute and 45% of chronic cases. There is no
specific treatment for hepatitis A, but most recover. A vaccine is
available for those at increased risk (travelers to endemic areas, the
elderly, etc.). Acute hepatitis B is usually not fatal. Chronic hepatitis
B may result in cirrhosis or hepatic cancer. Hepatitis B is vaccine-
preventable. Hepatitis C virus mutates quickly; only 10-15% re
cover from the acute infection; in 85% infection persists and may be
benign or progress to cirrhosis or cancer eventually. Both B and C
virus infections are treated with interferon.
Next Dr Robert B. Baron discussed the treatment of hypercholes
terolemia. Men should be screened starting at 45 and women at 55.
Both LDL and HDL should be determined. Triglycerides are not an
independent risk factor for CHD. Treatment should begin with diet
and exercise, and drug therapy reserved for those at high risk of
CHD. Those over age 75 should not be treated if there is no evidence
of CHD yet. Dr Baron then described the various drugs which can
be used and the indications for them.
In a second presentation Dr Baron discussed the treatment of
obesity. One third of adults in the US are obese (more than 20%
above desirable weight). With dietary treatment 20% will achieve
and maintain a 20 lb. weight loss; only 5% will lose 40 lb. and
maintain it. Body Mass Index is more important than body fat. BMI
over 40 = morbid obesity. Prevention of obesity is more effective
than treatment. People lose weight with very low calorie diets and
exercise but this usually doesn’t last. The only predictor of success
in maintaining weight loss is continuing exercise. The goal is to lose
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fat, not muscle. Resistance training preserves muscle mass.
Fenfluramine and dexfenfluramine are now off the market because
of their association with cardiac valvular disease. Some new drugs
are being tested but not yet approved.
In the concurrent session on Women’s health issues, Dr Edwin
Gramlich described premenstrual syndrome of which about 75% of
women have symptoms during their reproductive years and various
options for treatment: life-style changes (diet, exercise, stress reduc
tion), and possible use of SSRIs when symptoms are severe.
Next Dr Ken Arakawa discussed the prevention and treatment of
osteoporosis. Osteoporosis occurs in men but is much more com
mon in women. All postmenopausal women should have bone
density checked. Vertebral fractures usually occur earlier than hip
fractures and result in loss of height and deformity and pain. Hip
fractures result in 20% excess mortality in the first year. 50% never
recover fully. Management includes analgesics for pain, weight-
bearing exercise, prevention of falls, use of calcium and vitamin D.
Estrogens can be started 10-20 years post-menopause but must be
continued forever, but there may be an increased risk of breast
cancer. Calcitonin may be used with calcium and vitamin D.
Bisphosphanates prevent bone resorption; the newest of these,
alendronate (fosamax) has been approved by FDA for osteoporosis.
Dr Alan R. Katz’s topic was sexually transmitted diseases in
Hawaii. Chlamydia is most common both here and nationally.
Gonorrhea, AIDS and hepatitis B come next locally. Hawaii has
very little syphilis now. Chlamydia is treated with doxycycline or
azithromycin (erythromycin ifpregnant), and gonococcal infections
with cephalosporins.
Dr David Amberger’s topic was human papillomavirus and neo
plasms of the cervix. Various subtypes of the virus are implicated in
different neoplasms; adenocarcinoma, invasive squamous cell car
cinoma, small cell carcinoma, and condylomata. The highest inci
dence of infection with human papilloma virus is in young women,
the risk decreasing after age 30. Other risk factors for cervical
cancers are coexisting genital infections,, early intercourse, having
numerous sex partners, and smoking. 20% of pap smears initially
reported negatiye have abnormal cells on rescreening, usually
atypical squamous cells. 4500 women die of cervical cancer every
year: of these 1/3 have had negative pap smears in the previous 5
years.
Dr Merle Miura-Akamine discussed chronic pain management in
a managed care setting, focussing on the Kaiser Spine Clinic model.
Initial focus is on educating primary care physicians to manage pain.
Pain should be prevented ifpossible and treated early when it occurs.
It is important not to undermedicate. Meds used are NSAIDs,
narcotics, antidepressants, muscle relaxants and anticonvulsants. It
is better to dose around the clock, avoiding peaks and troughs of
blood levels. Injections, if necessary, are best in the acute phase.
Rest should be limited and early return to activity encouraged.
Exercises, walking, pool therapy may be important. If these mea
sures are not sufficient referral to physiatry spine clinic is indicated.
Next Dr Bruce Katsura discussed stroke rehabilitation and the
long term sequelae of stroke. Rehab encompasses prevention of
comorbid illness and medical complications, training for maximal
functional independence, and facilitating psychosocial coping. He
described common impairments after stroke and their frequency,
stages in recovery from hemiplegia and predictors of outcome, and
typical functional outcomes.
Kathleen Brown, PhD, spoke on the treatment and management of
dementia. The type of intervention is determined by the severity of
the impairment of brain function and which functions are lost.
Common concomitants of dementia are depression, delirium, anxi
ety, agitation, restlessness, sleep disturbances, hallucinations and
delusions, apathy and withdrawal. Family caregivers need to be
educated in management of these problems. Some dementias are
reversible: those due to emotional disturbance, metabolic disorders,
eye and ear disorders, nutritional disorders, tumors, trauma, and
infections.
Dr Richard I. Tsou discussed the evaluation and management of
urinary incontinence in adults, which affects 15-30% of those over
60, women twice as often as men. Patients should be referred to a
specialist if the diagnosis and management are unclear, if there is no
response to treatment trial, if there is hernaturia without infection,
recurrent urinary tract infections, severe urinary retention, pelvic
prolapse or prostate nodule.
Sunday morning’s program dealt with end-of-life issues. Dr Yank
Coble, AMA Trustee, presented the AMA position in opposition to
physician-assisted suicide. Patients should be encouraged to make
advance directives. Pain management and use of hospice are impor
tant.
Andi van der Voort, RN, discussed the Hemlock Society’s view
that patients should have a right to ask for help in dying and that it
is not humane to refuse. She supports enactment of a law which
would allow the physician, after the patient has submitted a written
request 3 times within a 15 day period, to prescribe a lethal oral dose
of barbiturate which the patient could fill and use when he chooses.
Pat Kalua, RN, talked about hospice programs which offer pallia
tive, not curative, care in a facility or in the patient’s home. Patient
and family, as a unit, are provided care and emotional support. Dying
can be a good experience. The most common fears of dying patients
are of pain, dependency, and the unknown.
Next Dr Max Botticelli discussed the physician’s role in the care
of the dying patient. The physician can help the patient define goals
for the remainder of his life and make rational decisions. Most
patients do not have living wills. Living wills are usually too vague
to be helpful and they do not protect the patient from unnecessary
care in ER or hospital. It would be dangerous to rely on patient
requests to die; physicians, including psychiatrists, are not good at
determining the competency ofdepressed patients. Emphasis should
be on control of pain, not possible side effects of adequate pain
control, and avoidance of unnecessary treatment.
Dr Reginald Ho moderated a panel discussion with these four
presenters. One point which was made is that the local drug enforce
ment unit in Hawaii understands the use of large doses of narcotics
in controlling the pain of terminally ill patients and will not pro
secute physicians unreasonably.
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